Ginkgo Bioworks Holdings (DNA) Return on Capital Employed Growth (1y) (2022 - 2026)
Ginkgo Bioworks Holdings (DNA) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | -3,457.00 |
| 10 | Ginkgo Bioworks Holdings | 450.30 Mn | 306.44 Mn | 16.38 Mn | 807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 807.00 |
| Dec 31, 2025 | 1,331.00 |
| Sep 30, 2025 | 1,302.00 |
| Jun 30, 2025 | 3,402.00 |
| Mar 31, 2025 | 1,890.00 |
| Dec 31, 2024 | 905.00 |
| Sep 30, 2024 | 198.00 |
| Jun 30, 2024 | -154.00 |
| Mar 31, 2024 | 1,967.00 |
| Dec 31, 2023 | 5,731.00 |
| Sep 30, 2023 | 15,656.00 |
| Jun 30, 2023 | 10,180.00 |
| Mar 31, 2023 | 5,192.00 |
| Dec 31, 2022 | -1,617.00 |
| Sep 30, 2022 | -19,183.00 |
| Jun 30, 2022 | -14,844.00 |